The government will conduct a randomised controlled clinical trial to assess the efficacy of Ayurvedic drug Ashwagandha as a preventive intervention among healthcare professionals and high-risk coronavirus population in comparison with hydroxychloroquine.
This will be a joint initiative of the ministries of AYUSH, health, and science and technology through the Council of Scientific and Industrial Research (CSIR) with technical support from the Indian Council of Medical Research (ICMR).
The Interdisciplinary Ayush R&D Task Force has formulated and designed clinical research protocols for prophylactic studies and add-on interventions in Covid-19 positive cases thorough review and consultative process of experts of high repute from different